Pokrovskaya Hospital, St. Petesburg, Russia Report issue

Academic/Hospital Phase 2 Phase 4

Organization Overview

First Clinical Trial
2005
NCT00334386
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Pokrovskaya Hospital, 1-st and 2-nd Cardiology Department, St. Petesburg, Russia | St. Petersburg state budgetary institution of health care " city Pokrovskaya hospital"

Active Ingredients

Drugs in Phase 4 Trials (1)

torsemide (demadex) (1 trial)

Drugs in Phase 2 Trials (2)

cefepime (maxipeme) (1 trial)

fluticasone (cutivate) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Communicable Diseases (Phase 2)

Hypertension (Phase 4)

Infections (Phase 2)

Pseudomonas Infections (Phase 2)

Urinary Tract Infections (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 3